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Objectives. Because sudden death due to complete atrioventric- 
ular (AV) block or ventricular arrhythmias i  the most dramatic 
event in myotonic dystrophy, we assessed the relation of cardiac 
disease to cytosine-thymine-guanine (CTG) triplet mutation in 
adults affected with myotonic dystrophy. 
Background. The myotonic dystrophy mutation, identified as an 
unstable deoxyribonucleic a id (DNA) sequence (CTG) prone to 
increase the number of trinucleotide repeats, produces clinical 
manifestations of the disease in skeletal muscle, the heart and 
many organ systems. 
Methods. Forty-two adult patients underwent electrocardio- 
graphy and echocardiography; in addition, signal-averaging elec- 
trocardiography was performed in22, and 24-h Holter monitoring 
was recorded in 32. The diagnosis was established by neurologic 
examination, electromyography, muscle biopsy and DNA analysis. 
The patients were then classified into three subgroups on the 
basis of the number of CTG trinucleotide repeat expansions: E~ = 
18 patients with 0 to 500 CTG repeats; Ez = 12 patients with up 
to 1,000 repeats; E3 + E 4 = 10 patients with up to 1,500 repeats 
and 2 patients with >1,500 repeats. 
Results. The incidence of normal electrocardiographic (ECG) 
results was found to be significantly different in the three sub- 
groups (55%, 50%, 17% in El, Ez, E 3 + E4, respectively, p = 0.04), 
with the highest values in the group with fewer epeat expansions. 
The incidence of complete left bundle branch block was also 
significantly different among the groups (5% in El, 0% in Ez, 42% 
in E3 + E4, p = 0.01) and was directly correlated with the size of 
the expansion. A time-domain analysis of the signal-averaged 
ECG obtained in 12 patients in El, 4 in Ea, 5 in E 3 and 1 in E 4 
showed that abnormal ventricular late potentials were directly 
correlated with CTG expansion (33% in E~, 75% in E2, 83% in 
E 3 + E4, p = 0.05). Moreover, the incidence of ventricular 
couplets or triplets howed apositive correlation with size of CTG 
expansion (0 in El, 0 in E2, 29% in E 3 + E4, chi square 0.02). 
Conclusions. Our findings suggest hat the involvement of 
specialized cardiac tissue, accounting for severe AV and intraven- 
tricular conduction defects, is related to CTG repeat length. In 
addition, the presence of abnormal late potentials directly corre- 
lates to CTG expansion. Abnormal ate potentials, caused by 
slowed and fragmented conduction through damaged areas of 
myocardium, represent a substrate for malignant reentrant ven- 
tricular arrhythmias. In the future, therefore, molecular analysis 
of DNA should identify patients with cardiac disease at high risk 
for development ofAV block or lethal ventricular arrhythmias. 
(J Am Coll Cardiol 1995;25:239-45) 
Myotonic dystrophy, the most common muscular dystrophy in 
adults (1), has multiple systemic effects, including neuromus- 
cular manifestations, cataracts, mental retardation and cardiac 
involvement. Overt primary myocardial disease in myotonic dys- 
trophy is rare, but conduction disturbances are frequent (2-5). 
Moreover, patients with myotonic dystrophy are reported to have 
a higher incidence of sudden death than the general population, 
and the observed eaths occur either from complete atrioventric- 
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ular (AV) block or ventricular arrhythmias (4,6-8). Myotonic 
dystrophy is an autosomal dominant disorder with incomplete 
penetrance and variable expressivity. The myotonic dystrophy 
mutation was recently identified as an unstable trinucleotide 
cytosine-thymine-guanine (CTG) repeat, resulting in a variable- 
length polymorphism, which maps to chromosome 19q 13.3 and is 
located within a 10-kilobase (kb) deoxyribonucleic a id (DNA) 
sequence (9-11). The trinucleotide repeat, which is present 5 to 
30 times in the normal population, was found to be amplified 
up to 2,000 times in patients with myotonic dystrophy (12-14). 
In a previous tudy (15), the age at onset and the severity of 
skeletal muscular disease were reported to be correlated with 
CTG trinucleotide amplification. Because sudden death is the 
most dramatic event in myotonic dystrophy, the purpose of this 
study was to assess the relation between the severity of cardiac 
disease and CTG trinucleotide repeat length. 
©1995 by the American College of Cardiolo~, 0735-1097/95/$9.50 
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Methods 
Patients. We studied 42 patients (30 men, 12 women; mean 
[_+SD] age 39 _+ 4 years, range 18 to 82) from 24 myotonic 
dystrophy pedigrees. Myotonic dystrophy was diagnosed in our 
Neuromuscular Center on the basis of neurologic examination, 
electromyography, muscle biopsy and DNA analysis (16). This 
diagnosis was also based on a positive family history compat- 
ible with an autosomal dominant inheritance. Clinical variables 
evaluated included neuromuscular manifestations, ocular ab- 
normalities and cardiac disease. The severity of skeletal muscle 
involvement was scored as follows: mild = myotonia only by 
either clinical examination relectrophysiologic study; moder- 
ate = muscle atrophy in the distal forearm or leg muscles; 
severe = marked limb hypotonia, severe muscle atrophy or 
severe weakness resulting from involvement of facial, neck and 
distal limb muscles. Clinical evaluation and grading were 
performed throughout by the same observer. 
Cardiac evaluation. Cardiac evaluation in all 42 patients 
was based on history, physical examination, chest radiography, 
electrocardiography and echocardiography. In addition, signal- 
averaging electrocardiography was performed in 22 patients, 
and 24-h Holter monitoring was recorded in 32. Intracardiac 
electrophysiologic studies were performed in only the three 
symptomatic patients. These invasive methods would have 
provided additional data about the abnormalities of impulse 
formation and conduction in the other patients, but for the 
purpose of the present study, we focused on the scalar elec- 
trocardiogram (ECG), Holter monitoring and the signal- 
averaged ECG. 
Signal-averaged ECG. The signal-averaged ECG was re- 
corded in the absence of drug therapy using a commercially 
available system (Marquette MAC 15) during sinus rhythm 
(standard bipolar orthogonal leads x, y and z); 250 beats were 
averaged to obtain a noise level of <0.6/zV. The signals were 
amplified, digitized, averaged and filtered with a bidirectional 
filter at frequencies of 40 to 250 Hz. Late potentials were 
considered tobe present in patients with normal ECG findings 
or with hemiblock if two or three standard variables were 
abnormal: filtered QRS complex duration ->117 ms, filtered 
complex duration after the voltage decrease to <40 p~V 
->34 ms and root-mean-square voltage during the last 40 ms of 
the filtered QRS complex -<24 p~V (normal values in our 
laboratory _+1 SD). In patients with complete right or left 
bundle branch block, these variables were considered abnor- 
mal as follows: filtered QRS duration ->145 ms; filtered 
complex duration ->45 ms after the voltage decrease to 
<40 p~V and root-mean-square voltage -<17 p~V during the last 
40 ms of the filtered QRS complex (17). Twenty-four hour 
Holter monitorings were obtained using modified leads V1 and 
V 5 and a portable ICR 24-h tape recorder. Tapes were 
analyzed by a rapid scanner with a digital circuit for arrhythmia 
detection and date reduction (Pathfinder model 3). During 
24-h Holter monitoring, the patients followed their normal 
daily routine and kept a diary of symptoms and activity levels. 
Ventricular arrhythmias were classified according to the Lown 
scale. 
A phased-array ultrasound system (Sonos 1000 77030 A) 
with duplex 2.5- and 3.5-MHz transducers and a 2.0-MHz 
nonimaging transducer for imaging, spectral Doppler and 
color flow mapping was used. Standard parasternal, apical and 
subcostal views were stored on Panasonic AG 6200 videotapes 
that allowed frame-by-frame and real-time playback for de- 
tailed evaluation of structures and function. Two-dimensional 
studies were evaluated by two independent observers. Left 
ventricular volumes were calculated using an ellipsoid area- 
length model derived from left ventricular imaging in the 
apical four-chamber view. Ejection fraction was calculated as 
follows: end-diastolic volume minus end-systolic volume di- 
vided by end-diastolic volume (18). End-diastolic and end- 
systolic right ventricular volumes were calculated by an area- 
length method derived from orthogonal planes (apical four- 
chamber and short-axis ubcostal views) (19). 
After two-dimensional examination, mitral flow from the 
cardiac apex was evaluated by Doppler ultrasound; the sample 
volume was placed in the left ventricular inflow tract at the 
level of the mitral leaflet tips (20,21). Variables of diastolic 
function included 1) early (E) and atrial (A) filling velocity 
peaks; 2) ratio of early to atrial peaks (E/A); 3) time-velocity 
integral of the atrial and early filling velocity curves; and 
4) ratio of time-velocity integral of early filling velocity curve 
to time-velocity integral of atrial filling velocity curve. 
The following criteria for the presence of mitral valve 
prolapse on echocardiography were applied: bowing of mitral 
leaflet(s) extended >5 mm above the plane of the mitral ring 
in the parasternal long-axis, four-chamber view; left atrial 
coaptation point; and moderate or severe Doppler mitral 
regurgitation with any degree of leaflet bowing (22,23). 
DNA analysis. Twenty milliliters of venous blood was 
collected from each of the 42 patients. The range of CTG 
amplification i  DNA was evaluated in a control group of 100 
adult donors from the National Blood Transfusion Centre of 
the Italian Red Cross, Rome. Genomic DNA (10 /~g) was 
digested with EcoRI or BamHI restriction enzymes, according 
to the manufacturer's in tructions (Bio-Rad), electrophoresed 
on 0.8% agarose gels and transferred onto nylon membranes 
(Hybond N, Amerrsham). Southern blots were probed with the 
1.4-kb Barn-HI fragment on the MDY 1 cosmid containing the 
variable CTG repeat (12). Hybridime (HT Bioteehnology) was 
included at a concentration f 0.25 mg/ml in both the prehy- 
bridization and hybridization solutions. Blots were washed in 
1 × sodium chloride/sodium citrate (SSC) and 0.1% sodium 
dodecyl sulfate (SDS) at 65°C and then exposed to AGFA 
XAR film for 1 to 4 days. CTG polymorphism was detected by 
the polymerase chain reaction technique using 101 and 102 
flanking synthetic oligonucleotides, according to Brook et al. 
(24). The number of CTG trinucleotide repeats was estab- 
lished for each patient by length variation on Southern blotting 
(EcoRI and/or BamHI) and polymerase chain reaction. 
CTG trinucleotide amplification. The CTG trinucleotide 
repeat length was classified using the following scale: E 1 = 
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Figure 1. Correlation between CTG repeats, the molecular cause of 
myotonic dystrophy, and age at disease onset, r = 0.39, p < 0.0001. 
ctg = cytosine-thymine-guanine. 
expansion of 0 to 1.5 kb (corresponding to 0 to 500 CTG 
repeats), 18 patients; E2 = expansion of 1.5 to 3.0 kb (up to 
1,000 repeats), 12 patients; E3 = expansion of 3.0 to 4.5 kb (up 
to 1,500 repeats), 10 patients; E 4 = expansion >4.5 kb (>1,500 
repeats), 2 patients. Because the number of patients in the E 4 
category was very small, the entire group was subdivided into 
three subgroups (El, E2, E3 + E4). 
Statistical nalysis. Continuous variables were analyzed by 
a general linear model procedure for unbalanced ata. The 
data were stratified according to age and entity of CTG 
expansion. Mean values were compared for significant differ- 
ences by the Tukey all-pairwise comparisons. Categoric vari- 
ables were analyzed by means of contingency tables according 
to the entity of CTG expansion. Different risk rates were tested 
by the Mantel-Haenszel chi-square method. Significant vari- 
ables were further analyzed with a test for logistic trend to take 
the increasing entity of CTG expansion i to account to control 
for age confounding. The age of patients was forced in the 
logistic model. 
Linear regression analysis was used to assess the correlation 
between the age at disease onset and CTG expansion. The 
linear correlation between skeletal muscle involvement and 
CTG expansion was tested using the Spearman rho test. The 
difference in CTG expansion among the four subgroups of 
progressive skeletal involvement was tested for significance 
using the general linear model analysis of variance Fisher least 
significant difference test. 
Results 
Age at onset and skeletal muscle involvement. The age of 
our patients at disease onset ranged from 10 to 80 years (mean 
[_+SD] 27.5 _+ 13.4). We observed an inverse correlation 
between age at disease onset and CTG expansion (Fig. 1), (r = 
0.39, p <0.0001). No skeletal muscle involvement was found in 
7 patients (17%); muscular involvement was mild in 8 (19%), 
moderate in 7 (17%) and severe in 20 (47%). A direct 
correlation between expansion and skeletal muscle involve- 
ment is shown in Figure 2; patients with severe involvement 
had a significant increase in the number of CTG triplets (mean 
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Figure 2. Distribution of skeletal muscle severity in the three sub- 
groups of patients, grouped according to extent of CTG expansion: 
El = 0 to 500 CTG repeats; E 2 = up to ],000 repeats; E 3 = up to 1,500 
repeats; E 4 = >1,500 repeats; ctg = cytosine-thymine-guanine. 
[_+SD] 935 + 402), whereas patients with no, mild or moderate 
involvement had intermediate CTG repeat lengths (mean 
[_+SD] 230 +_ 346, 457 _ 307, 525 _+ 225, respectively, p < 
0.05). 
Cardiac involvement. Only three patients were clinically 
symptomatic, with near-syncope manifestations. Most of the 
patients were asymptomatic, and 18 (43%) had normal findings 
on ECG tracings. Table 1 reports the percent of ECG abnor- 
malities observed. However, more than one abnormality was 
present in one subject, and a multilevel conduction system 
impairment was evident in eight: four had a first-degree AV 
block plus left anterior fascicular block; two had a first-degree 
AV block plus complete left bundle block; one had a first- 
degree AV block plus right bundle block and complete left 
bundle block; and one had a first-degree AV block plus right 
bundle block and left fascicular block. Two symptomatic 
patients had a first-degree AV block with anterior fascicular 
block and a right bundle branch block with anterior fascicular 
block, respectively. Electrophysiologic study documented the 
presence of an infrahisian block in both patients, with HV 
intervals of 80 and 95 ms, respectively, and pacemakers were 
implanted. 
The third symptomatic patient had a sinus bradycardia and 
a first-degree AV block. However, electrophysiologic study did 
not detect sinus node dysfunction or infrahisian block (AH 
Table 1. Electrocardiographic Data for 42 Patients With 
Myotonic Dystrophy 
ECG Findings No. (%) of Pts 
Normal 18 (43) 
First-degree AV block 12 (28) 
LAFB 7 (16) 
LPFB l (2) 
RBBB 7 (16) 
CLBBB 6 (14) 
AV = atrioventricular; ECG = electrocardiographic; LAFB (LPFB) - left 
anterior (posterior) fascicular block; Pts = patients; RBBB (CLBBB) = right 
(complete left) bundle branch block. 
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Table 2. Clinical and Electrocardiographic Data for Patients With 
Myotonic Dystrophy Grouped According to the Extent of CrG 
Triplet Expansion 
E~ E 2 E 3 + E 4 
(n = 18) (n = 12) (n - 12) 
Mean age (yr) 46 35 35 
Gender 
Male 14 (78%) 9 (75%) 7 (58%) 
Female 4 (22%) 3 (25%) 5 (42%) 
ECO findings 
Normal l0 (55%) 6 (50%) 2 (17%)* 
First-degree 7 (38%) 1 (8%) 4 (33%) 
AV block 
LAFB 2 (11%) 2 (17%) 3 (25%) 
LPFB 0 1 (8%) 0 
RBBB 1 (5%) 2 (17%) 4 (33%) 
CLBBB l (5%) 0 5 (42%)? 
Pacemaker 0 0 2 (17%) 
*Mantel-Haenszel chi square 0.04; p = 0.04, for logistic trend; odds ratio 
0.39 × unit. tMantel-Haenszel chi square 0.01; p = 0.03, for logistic trend; odds 
ratio 10 × unit. Data presented are number (%) of patients. E~ = expansion of 
0 to 1.5 kb (corresponding to 0 to 500 CTG repeats); E 2 - expansion of 1.5 to 
3.0 kb (up to 1,000 repeats); E3 = expansion of 3.0 to 4.5 kb (up to t,500 repeats); 
E4 = expansion >4.5 kb (>1,500 repeats); other abbreviations as in Table 1. 
interval 190 ms, HV interval 60 ms). The three symptomatic 
patients were followed up in our outpatient department. After 
pacemaker implantation, no further attacks appeared in one 
patient; therefore, we believe that the near syncope in this 
patient should be attributed to paroxysmal complete AV block. 
In contrast, the other two patients, one with and one without a 
pacemaker, continued to have near-syncopal episodes. In these 
patients a vasovagal vasodepressive pathogenesis or ventricular 
tachyarrhythmia was probably the underlying mechanism. 
Relation between ECG and CTG expansion. The incidence 
of the single ECG abnormality in the three subgroups is 
reported in Table 2 according to the size of the CTG expan- 
sion. The incidence of normal ECG results was significantly 
different in the three subgroups, with highest values in the less 
expanded classes. The age-unconfounded odds ratio was 0.39. 
The incidence of complete left bundle branch block was 
directly correlated with CTG trinucleotide repeat length. The 
age-unconfounded odds ratio was 10. 
Relation between presence of abnormal ventricular late 
potentials and CTG expansion. The presence of abnormal 
ventricular late potentials was investigated in 22 patients. 
Figure 3 reports the incidence of abnormal ventricular late 
potentials in these patients, subdivided on the basis of CTG 
expansion (E~ in 12 patients, E2 in 4, E 3 + E 4 in 5 and 1, 
respectively). A positive trend between the presence of abnor- 
mal late potentials and number of CTG repeats is evident 
(Mantel-Haenszel chi square 0.04; p = 0.05, for logistic trend). 
The age-unconfounded odds ratio was 3.3. 
Echocardiographie data. Echocardiograpfiic data for our 
patients with myotonic dystrophy are summarized in Table 3. 
We calculated right and left ventricular volumes as well as 
ejection fraction for both ventricles by two-dimensional echo- 
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Figure 3. Incidence of abnormal ventricular late potentials in the three 
subgroups of patients with myotonic dystrophy, grouped according to 
extent of CTG expansion. Mantel-Haenszel chi square 0.04; p -- 0.05, 
for logistic trend; odds ratio 3.3 × unit. Abbreviations as in Figure 2. 
cardiography and evaluated diastolic function by Doppler 
ultrasound. Compared to the control group, only a mild, 
statistically significant dilation of the right ventricle was ob- 
served (p < 0.01). We used ratio of early (E) to atrial (A) 
filling velocity peaks and ratio of time-velocity integral of early 
velocity curve (IE) to atrial curve (IA) as indexes of diastolic 
function. Comparisons of such indexes between the patients 
and the control subjects are shown in Table 3. No significant 
differences between groups were observed for E/A or IE/IA. 
However, three patients had abnormal ratios. We defined an 
abnormal E/A (<1) ratio and an abnormal IE/IA (<1.5) ratio 
as less than the mean value -2  SD in control subjects. In two, 
abnormal ratios were associated with left ventricular hypertro- 
phy and systemic arterial hypertension, and in one other with 
regional wall motion abnormalities. On the basis of strict criteria 
to confirm the abnormality of mitral leaflet structure and func- 
tion, a mitral prolapse was diagnosed in seven patients (17%). 
Table 3. Echocardiographic and Doppler Ultrasound Data for 42 
Patents With Myotonic Dystrophy 
Mean _+ SD Min Max 
Control Subjects 
(mean + SD) 
(n = 38) 
LV end-diastolic volume 57 _+ 11 38 91 64 _+ 6 
(ml/m 2) 
LV ejection fraction (%) 62 _+ 5.9% 50 74 57 _+ 3 
LV mass (g/m e) 1.08 _+ 0.13 0.8 1.3 
RV end-diastolic 63 _+ 14 36 95 48 _+ 6* 
volume (mllm z) 
RV ejection fraction (%) 62 + 5 52 72 60 - 5 
E/A 1.5 -+ 0.6 0.66 3.3 1.6 -+ 0.31 
IE/IA 2.4 -+ 1.4 1 6.7 2.7 _+ 0.62 
*p < 0.01. E/A = ratio of peak early filling velocity (E) to peak atrial filling 
velocity (A); IE/IA = ratio of time-velocity integral of early filling velocity curve 
to time-velocity integral of atrial filling velocity curve; LV = left ventricular; 
Max = maximum; Min = minimum; RV = right ventricular. 
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Table 4. Echocardiographic Data for Patients With Myotonic 
Dystrophy Grouped According to Extent of CTG Triplet Expansion 
El E2 E 3 + E 4 
(n = 18) (n = 12) (n = 12) 
LV end-diastolic volume (ml/m 2) 55 55 61 
LV ejection fraction (%) 63 60 62 
LV mass (g/m 2) 1.10 1.07 1.02 
RV end-diastolic volume (ml/m 2) 65 60 61 
RV ejection fraction (%) 61 62 61 
E/A 1.4 1.43 1.60 
IE/IA 2.27 2.45 3.30 
Abbreviations as in Tables 2 and 3. 
Myocardial function and CTG expansion. No significant 
difference xisted among the three subgroups of patients with 
myotonic dystrophy with regard to left ventricular end-diastolic 
volumes and ejection fraction, right ventricular data or left 
ventricular diastolic function (Table 4). 
Arrhythmias and CTG expansion. Both bradyarrhythmias 
and tachyarrhythmias were evaluated. Table 5 shows the 
various arrhythmias that were detected in the patients with 
myotonic dystrophy along with the size of the CTG expansion. 
It appears that the most serious ventricular arrhythmias (cou- 
plets or triplets) occurred in the E 3 + E 4 subgroup. 
Discuss ion  
Previous studies. Myotonic dystrophy is an autosomal neu- 
romuscular disorder characterized byextremely variable phe- 
notypic expression and age of onset. Cardiac involvement isan 
integral part of myotonic dystrophy, targeting almost selec- 
tively the conduction system and, less specifically, the myocar- 
dium. Sudden death is the most grave cardiac threat and has 
been related to conduction block or malignant ventricular 
arrhythmias. The myotonic dystrophy gene was recently iso- 
Table 5. Twenty-Four Hour Holter Monitoring in Patients With 
Myotonic Dystrophy Grouped According to Extent of CrG 
Triplet Expansion 
E~ E 2 E 3 + E¢ 
(n - 16) (n - 9) (n = 7) 
Normal 5 (31%) 2 (22%) 2 (29%) 
Sinus atrial block 1 (6%) 1 (11%) 0 
Sinus arrhythmia 2 (12%) 1 (11%) 1 (14%) 
Sinus bradycardia 2 (12%) 3 (33%) 0 
Second-degree AV block (type I) 0 1 (11%) 0 
PSVB 1 (6%) 1 (11%) 1 (14%,) 
PVB < 30/h 4 (25%) 2 (22%) 2 (29%) 
PVB > 30/h 0 0 1 (14%) 
Couplets or triplets 0 0 2 (29%)* 
ST segment alterations 1 (6%) 0 0 
His bundle recording I (6%) 0 2 (29%) 
*Mantel-Haenszel chi square 0.02. Data presented are number (%) of 
patients. PSVB - premature supraventricular beats; PVB = premature ventric- 
ular beats; other abbreviations a  in Table 2. 
lated, and the molecular defect characterizing the myotonic 
dystrophy mutation was identified as an unstable DNA se- 
quence (CTG repeat) at the T-untranslated region of a 
serine-threonine kinase gene located on 19q (12) encoding for 
a protein that was designated as myotonin. 
The myotonin amino acid sequence is similar to a protein 
kinase that should act as second cell messenger (12,24). 
However, the effect of the repeat on gene transcription is still 
controversial, and it is not clear whether the mutation isa loss 
(25) or a gain in protein production function (26). In any case, 
this recognized mechanism of"dynamic mutation" (27-34) has 
provided a molecular explanation for the unusual genetic 
features observed in families with myotonic dystrophy, such as 
anticipation (30-32), clinical variability (34) and incomplete 
penetrance (29). Anticipation corresponds to a more severe 
expression and an earlier onset of the disease through gener- 
ations as a result of the increase in the number of CTG repeats 
with subsequent generations through the affected pedigrees. 
The opposite phenomenon, "reverse mutation" (28), is a 
meiotic regression in the size of the triplet expansion, which 
would bring the number of CTG repeats within the normal 
range and might account for incomplete penetrance; however, 
it seems to be a rare event. 
Present study, In the current investigation we found a 
direct relation among degree of skeletal muscle involvement, 
earlier age at disease onset and expansion of the unstable 
sequence, in agreement with a previous report by Novelli et al. 
(15). Moreover, by relating the myotonic dystrophy genotype 
to cardiac involvement, we observed a direct relation among 
specialized tissue disease, ventricular arrhythmias and CTG 
expansion. 
Correlation between ECG data and CTG expansion. Overt 
clinical symptoms, uch as syncope or near syncope, were rare 
in our patient series, but ECG findings, consisting of conduc- 
tion defects, were abnormal in 57% of the patients. 
A significant inverse difference in the incidence of normal 
ECG findings was found among the three subgroups classified 
on the basis of CTG expansion. By contrast, a significant, direct 
correlation between complete left bundle branch block and 
CI'G expansion was evident. 
Correlation between ventricular rhythmias nd CTG expan- 
sion. Sudden death has also been reported in patients with 
well functioning pacemakers, soventricular arrhythmias seem 
to play an important role in the genesis of sudden death (6-8). 
In our patients, malignant ventricular premature beats (ven- 
tricular couplets or triplets) were observed on 24-h Holter 
monitoring, and the incidence of these arrhythmias showed a 
positive, significant rend with the size of CTG expansion. 
Because signal-averaged lectrocardiography canidentify pa- 
tients at high risk for lethal ventricular rrhythmias nd sudden 
death (35,36), presumably by identifying the electrical mani- 
festations of the anatomic substrates of these arrhythmias 
(37-38), we evaluated a smaller group of the study patients by 
this method. Milner et al. (39) previously showed that the 
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prevalence of late potentials on signal-averaged electrocardio- 
graphy in patients with myotonic dystrophy approached that 
seen in cardiac patients with inducible ventricular tachycardia. 
A time-domain analysis of the signal-averaged ECG in our 
patients with myotonic dystrophy showed a significantly higher 
prevalence of abnormal delayed electrical activity in subjects 
with the most expanded CTG repeats. It is possible that focal 
areas of necrosis in the myocardium, and particularly in the 
primary conduction tissues, might be the site of the delayed 
electrical conduction detected in our series. 
Ventricular myocardial function. Controversy exists regard- 
ing the prevalence ofpreclinical left ventricular dysfunction i
patients with myotonic dystrophy (40-45) who have no symp- 
toms of heart failure, but overt signs of heart failure are rarely 
reported (5,46). In the current study, only a mild, statistically 
significant dilation was observed, in agreement with previously 
described structural abnormalities of the right ventricle (5). 
The aforementioned right ventricle dimensional and structural 
abnormalities could constitute the anatomic substrate for late 
potentials and arrhythmias. Indeed, no significant difference in 
left and right ventricular findings emerged in the three patient 
subgroups, classified on the basis of CTG expansion. In the 
current study, in only one patient could diastolic dysfunction 
be related to a myocardial dystrophic disease because the 
increase in peak atrial velocity was associated with wall motion 
abnormalities. 
Conclusions. Our present study agrees with previous re- 
ports of a high incidence of conduction system defects and 
ventricular arrhythmias in patients with myotonic dystrophy. 
The ECG-molecular correlation that we observed could pro- 
vide some information regarding the morbidity and prognosis 
in these patients. A predictive diagnosis obviously cannot be 
made in isolated cases solely on the basis of repeat length 
because there is a clear and significant overlap between the 
expansion sizes seen in the different phenotypic groups. So- 
matic mosaicism (i.e., the coexistence in the same subject of 
cell lines with different numbers of CTG repeats) constitutes a
limiting factor; DNA is routinely obtained from lymphocytes 
and therefore may differ (in terms of CTG repeats) from the 
DNA of the specialized conduction system tissue. 
Anvret et al. (67) compared DNA from blood and muscle 
samples from the same subject; the length of the repeat unit 
demonstrated somatic heterogeneity and was much greater in 
all the muscle samples. Therefore, to obtain a more precise 
correlation, it would be necessary to study DNA isolated from 
the cardiac muscle of patients with myotonic dystrophy. Al- 
though this may be possible in isolated patients undergoing 
electrophysiologic studies, ethical considerations would other- 
wise clearly preclude such an approach. Moreover, future 
studies should include messenger ibonucleic acid and myo- 
tonic dystrophy kinase from cardiac biopsy samples and attempt 
to detect he entity of kinase expression in this tissue compared 
with that in skeletal muscle. The underlying mechanism of 
myotonic dystrophy in the heart might thus be clarified. 
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